Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche's European in vitro device business to be folded into Boehringer Mannheim's under integration plan.

This article was originally published in The Gray Sheet

Executive Summary

ROCHE EUROPEAN DIAGNOSTICS UNITS WOULD BE FOLDED INTO BOEHRINGER FACILITIES under Roche's integration plan for Boehringer Mannheim. The proposal, which would eliminate 4,000-5,000 of the combined companies' 74,000 employees, calls for Boehringer to take over the functions of Roche's Kaiseraugst, Switzerland and Grenzach, Germany in vitro diagnostics operations. Roche announced a definitive agreement to purchase Boehringer Mannheim parent Corange on May 26 ("The Gray Sheet" June 2, p. 3); the deal is expected to close by the end of the year.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009071

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel